Main > A1. CORP. INDEX. B-Bm > Baxter /P C2

---

This data is not available for free

Baxter /P C2's subsections
2002. 06.17.2002. (Business Acq.)
2002. 06.24.2002. (NanoTech.)
2002. 09.23.2002. (Funding R&D of)
2002. 09.23.2002. (ShareHolder of)
2002. 11.18.2002. (Drug Deliv.)
2002. 11.18.2002. (Parent of)
2003. 03.20.2003. (Executive)
2003. 03.20.2003. (Mfg. Plant Acq.)
2003. 03.20.2003. (Subsidiary of)
2003. 05.26.2003. (Fungi/Protein)
2003. 07.07.2003. (Plasma Therapy)
2004. 04.04.2004. (Alliance)
2004. 04.04.2004. (Focus)
2007. 12.18.2007. (Surgery >) >
2008. 03.16.2008. ImmunoDeficiency
2008. 03.20.2008. Surgery>Burn Care
2008. 03.24.2008. Heparin
2008. 05.12.2008. CEO
2009. 10.07.2009. H1N1 Flu Vacc.
2010. 10.12.2010. New Bus.
2010. 10.25.2010. Pneumo.>Emphysema
2010. 11.18.2010. Renal.>HD System
2010. 11.19.2010. Archemix
2011. 02.15.2011. Appointments
2011. 03.02.2011. TriVal. Flu Vacc.
2011. 06.24.2011. Neuro.>MMN
2011. 07.25.2011. Immuno.>PI
2011. 07.28.2011. Baxter Ventures
2011. 08.31.2011. Facial Lift
2011. 12.22.2011. Momenta Pharma.
2012. 01.30.2012. Surgery>Hemostasi
2012. 02.28.2012. Cardio.>CMI
2012. 03.02.2012. Flu Vacc.
2012. 04.19.2012. Biologics Cap.
2012. 06.04.2012. Hemophilia B
2012. 06.25.2012. Neuro.>MMN
2012. 07.16.2012. Hemophilia A A
2012. 07.19.2012. Stichting Sanquin
2012. 09.19.2012. Onco.>MDS
2012. 09.28.2012. BoD
2012. 11.01.2012. BR HemoBras
2012. 12.04.2012. Gambro AB Acq.
2013. 01.24. Hemophilia A II
2013. 04.24. Lyme Dis. Vaccine
2013. 05.07. Neuro.>AD
2013. 07.31. Omega 3 Parenteral Nut
2013. 09.03. Biosimilars
2013. 11.15. Onco.>MyeloFibrosis
2013. 12.19. Hemophilia A&B>Inh Dev
2013. 12.20. Renal>HD System
2014. 01.30. Xenetic Biosciences
2014. 04.16. Von Willebrand Dis.
2014. 05.08. Hosp.>Infusion Pump
2014. 07.09. Acq. AesRx LLC>Sickle
2014. 07.30. Comm. Vacc. Bus. Sale
2014. 08.19. Hemodialysis Dialyzer
2014. 08.21. Hemophilia A>BAX 855
2014. 09.10. Sepn. in 2 Companies
2014. 09.12. Immuno.>PI
2014. 09.24. Onco.>Pancreas C.
2014. 09.29. BioPharma>Boston>R&D
2014. 11.04. CA>IV Admixing Faciity
2015. 01.20. Renal>CRRT
2015. 03.04. Acq. SuppreMol GmH.
2015. 04.01. Renal>APD System
2015. 06.01. Vitesse Biologics LLC
2016. 09.19. Preterm Newborns
2018. 09.04. Clinical Nutrition
2018. 09.06. Ortho.>Bone Graft
2018. 09.26. Ortho.>Bone Graft
2018. 10.29. Renal>CRRT
2019. 03.06. CV.>Eptifibatide
2019. 07.22. Ready-To-Use Insulin
2019. 07.29. USA Launch
2019. 08.12. CA Launch
2019. 09.10. Acq. Cheetah Medical
2019. 12.02. Adhesion Barrier
2020. 02.12. FDA 510(k) Clearance
2020. 02.18. Adhesion Barrier
2020. 04.23. COVID-19 Treat.>USA>E
2020. 05.20. EU CE Mark & AU>OK
2020. 07.09. U.S. FDA Clearance
2020. 09.23. Parenteral Nutrition
2020. 11.23. Nephro.>APD>USA>OK
2021. 03.12. AK 98 Hemodialysis Mac
2021. 12.13. Hillrom ACQ.
2022. 08.31. U.S. FDA Clearance
2023. 07.25. Kidney Care Spinoff
2024. 04.01. U.S. FDA Clearance
Baxter BioPharma Solutions C2
Baxter BioSurgery. C2
Baxter Vaccines C2
Baxter Ventures. C2
Patents
Prodts.>Infusion>Sigma Spectrum. C2
Web-Site
Z - OK

Baxter /P C2's products
This section has no products